KORRO BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.53 USD | -4.67% |
|
+7.85% | -23.78% |
| 01/07 | Korro Bio Joins Russell 2000, 3000, Microcap Indexes | MT |
| 01/07 | Korro Bio, Inc.(NasdaqCM:KRRO) added to Russell Small Cap Comp Value Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Korro Bio, Inc. is a biopharmaceutical company. The Company discovers, develops, and commercializes genetic medicines based on editing ribonucleic acid (RNA), enabling treatment of both rare and highly prevalent diseases. The Company is generating a portfolio of differentiated programs that are designed to harness the bodyâs natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, it is expanding the reach of genetic medicines. Its Oligonucleotide Promoted Editing of RNA (OPERA) is a foundational platform for RNA editing, which is designed to edit RNA in vivo by delivering an oligonucleotide guide that can target specific RNA sequences. The Companyâs first development candidate, KRRO-110, is in development as a potential treatment for Alpha-1 Antitrypsin Deficiency (AATD), that has the potential to be disease-modifying and provide a differentiated therapeutic option.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
36.53
USD
Average target price
126.2
USD
Spread / Average Target
+245.61%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -23.78% | 339M | |
| +18.97% | 45.34B | |
| +41.98% | 40.42B | |
| -10.06% | 37.92B | |
| +31.15% | 31.75B | |
| -7.79% | 27.71B | |
| +13.32% | 26.52B | |
| +43.05% | 13.96B | |
| +31.28% | 12.44B | |
| -7.41% | 11.26B |
- Stock Market
- Equities
- KRRO Stock
- News Korro Bio, Inc.
- Korro Bio Joins Russell 2000, 3000, Microcap Indexes
